Open, randomized trial of the effect of aripiprazole versus risperidone on social cognition in schizophrenia.

Trial Profile

Open, randomized trial of the effect of aripiprazole versus risperidone on social cognition in schizophrenia.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Aripiprazole; Risperidone
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2015 Status changed from active, no longer recruiting to completed.
    • 14 Jan 2010 New source identified and integrated (Netherlands Trial Register).
    • 02 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top